Life Sciences BC 2025-26 Board of Directors Announcement [Yahoo! Finance]
Jade Biosciences, Inc. (JBIO)
Company Research
Source: Yahoo! Finance
Board of Directors following its Annual General Meeting (AGM) on September 17, 2025. The Board of Directors is comprised of seasoned leaders dedicated to driving forward the growth of the life sciences sector. New and Returning Board Members and Observers LSBC welcomes Christina Zacharuk, CEO of Research Universities' Council of British Columbia, and Sandra Wong, Senior Manager, Access and Government Affairs of Pfizer Canada, who were each elected to three-year terms. Anne Stevens, VP Business Development of AbCellera, Michael Martin, Global Biopharmaceutical Executive, and Suzanne Gill, President & CEO of Genome British Columbia, were each re-elected to three-year terms. At the Board Meeting following the AGM, Hector MacKay-Dunn, KC, Joseph Garcia, and Roger Kuypers received renewed one-year appointments as Board Observers. The full slate of LSBC's Board of Directors is listed below. To learn more about our current board members, please visit our website: https://lifescienc
Show less
Read more
Impact Snapshot
Event Time:
JBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JBIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JBIO alerts
High impacting Jade Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
JBIO
News
- What Makes Jade Biosciences, Inc. (JBIO) a New Buy Stock [Yahoo! Finance]Yahoo! Finance
- Jade Biosciences (NASDAQ:JBIO) had its price target raised by analysts at Guggenheim from $14.00 to $17.00. They now have a "buy" rating on the stock.MarketBeat
- Jade Biosciences (NASDAQ:JBIO) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=JBIO&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street ZMarketBeat
- Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025 [Yahoo! Finance]Yahoo! Finance
- Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025GlobeNewswire
JBIO
Earnings
- 11/13/25 - Beat
JBIO
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/14/25 - Form S-1
- 11/14/25 - Form SCHEDULE
- JBIO's page on the SEC website